MARKET

BIIB

BIIB

Biogen Inc
NASDAQ
124.99
-3.70
-2.88%
After Hours: 126.33 +1.34 +1.07% 19:56 07/18 EDT
OPEN
129.37
PREV CLOSE
128.69
HIGH
129.58
LOW
124.68
VOLUME
1.52M
TURNOVER
--
52 WEEK HIGH
236.48
52 WEEK LOW
110.04
MARKET CAP
18.31B
P/E (TTM)
12.34
1D
5D
1M
3M
1Y
5Y
1D
Fastly, Biogen, Kroger, Bloom, Pure: Insider Sell-Offs!
TipRanks · 8h ago
Biogen Inc. Stock Slips 2.9%, Underperforms Competitors
Dow Jones · 1d ago
Biogen’s New Study on Felzartamab: A Potential Game-Changer for IgAN Treatment
TipRanks · 1d ago
Here's What to Expect From Biogen's Next Earnings Report
Barchart · 1d ago
Biogen’s Innovative Approach to SMA Treatment: The PIERRE-PK Study
TipRanks · 2d ago
Biogen’s New Study on MS Drug Vumerity: Key Insights for Investors
TipRanks · 2d ago
Biogen’s Promising Phase 3 Trial: Felzartamab for Kidney Transplant Rejection
TipRanks · 2d ago
Biogen’s Spinraza Study: Real-World Insights and Market Impact
TipRanks · 2d ago
More
About BIIB
Biogen Inc. is a global biopharmaceutical company. The Company is focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It operates a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS, and FUMADERM for the treatment of severe plaque psoriasis. It also collaborations with Eisai on the commercialization of LEQEMBI for the treatment of Alzheimer's disease and Sage on the commercialization of ZURZUVAE for the treatment of Postpartum Depression (PPD).

Webull offers Biogen Inc stock information, including NASDAQ: BIIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIIB stock methods without spending real money on the virtual paper trading platform.